Top Industry Leaders in the Epigenetics Market
Latest Epigenetics Companies Update
July 2023: FOXO Technologies Inc., a pioneer in the field of commercializing epigenetic biomarker technology, today announced the debut of its cutting-edge Bioinformatics Services to expedite advances in biology, biotechnology, and healthcare, and redefine the booming field of epigenetic research. Clients in the fields of academia, healthcare, and pharmaceutical research can take use of FOXO's Bioinformatics Services, which provide a comprehensive platform of sophisticated data solutions. FOXO's cutting-edge bioinformatics suite will help its customers handle, analyze, and interpret data sets more quickly and accurately, which in turn helps hasten the discovery process and expand our knowledge of complicated diseases. Gene regulation and the influence of lifestyle and environment on biological systems are both greatly aided by epigenetics.
April 2023: New duet multiomics solution from biomodal (formerly Cambridge Epigenetix) released in April 2023 promises to show the combinatorial power of genetic and epigenetic information from a single low volume sample. In a single sample, with a single procedure, and on any sequencer, the duet multiomics system allows for the simultaneous phased reading of genetic and epigenetic information. More epigenetic data may be gleaned from a small DNA library with this hardware-independent product than would be possible with sophisticated bioinformatics or toxic chemical treatment. Recently published in Nature Biotechnology, the method gives a more full view of the information stored in genomes affording fresh insights from applications throughout biomedicine.
List of Epigenetics Key companies in the market
- Bio-Rad (US)
- Illumina (US)
- QIAGEN (Netherlands)
- Thermo Fisher (US)
- Active Motif (US)
- Diagenode (Belgium)
- Agilent (US)
- Merck Millipore (US)
- Abcam (UK)
- New England Biolabs (US)
- PerkinElmer (US)
- Zymo Research (US).